Evid Invest
Who owns ALLOWhat ALLO owns — n/a

Who owns Allogene Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ALLO from SEC Form 13F filings across 197 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 197 institutions disclosed 303.8M shares of Allogene Therapeutics, Inc. worth $487.1M — about 87.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

197

13F holders

$487.1M

value, 2026 filers

87.8%

of shares outstanding (303.8M sh)

25

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ALLO's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.30.9M$49.5M0.0%8.9%+2.6%
2CITADEL ADVISORS LLC24.6M$39.3M0.0%7.1%+143.4%
3Frazier Life Sciences Management, L.P.22.4M$35.9M0.9%6.5%0.0%
4Pfizer Inc22.0M$36.4M22.1%6.4%0.0%
5STATE STREET CORP16.3M$26.1M0.0%4.7%-14.2%
6PRIMECAP MANAGEMENT CO/CA/13.1M$21.0M0.0%3.8%+0.2%
7VANGUARD CAPITAL MANAGEMENT LLC12.1M$19.3M0.0%3.5%-1.0%
8UBS Group AG10.7M$17.1M0.0%3.1%+252.3%
9FMR LLC10.6M$17.0M0.0%3.1%-11.7%
10Sio Capital Management, LLC9.1M$14.6M2.8%2.6%-31.7%
11TWO SIGMA INVESTMENTS, LP9.0M$14.4M0.0%2.6%+15.8%
12MARSHALL WACE, LLP8.0M$12.8M0.0%2.3%+56.5%
13GEODE CAPITAL MANAGEMENT, LLC6.4M$10.3M0.0%1.9%-8.5%
14Candriam S.C.A.5.4M$8.7M0.0%1.6%+25.1%
15GOLDMAN SACHS GROUP INC5.3M$8.5M0.0%1.5%-13.3%
16GordonMD Global Investments LP5.3M$8.5M5.1%1.5%0.0%
17Aberdeen Group plc5.3M$8.4M0.0%1.5%+5.2%
18RENAISSANCE TECHNOLOGIES LLC5.2M$8.4M0.0%1.5%+36.5%
19MILLENNIUM MANAGEMENT LLC5.1M$8.2M0.0%1.5%+5.6%
20Patient Square Capital LP4.5M$7.3M1.2%1.3%-9.9%
21D. E. Shaw & Co., Inc.4.3M$6.8M0.0%1.2%-9.5%
22VANGUARD PORTFOLIO MANAGEMENT LLC3.9M$6.2M0.0%1.1%-8.3%
23HRT FINANCIAL LP3.3M$5.4M0.0%1%-7.6%
24MORGAN STANLEY3.3M$5.3M0.0%1%-26.2%
25RTW INVESTMENTS, LP3.3M$5.2M0.1%0.9%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.